<--- Back to Details
First PageDocument Content
Date: 2016-11-29 01:36:20

A First-in-Man Phase 1a Study of the Bispecific Anti-DLL4/Anti-VEGF Antibody OMP-305B83 in Patients with Previously Treated Solid Tumors Jimeno A1, Moore K2, Gordon M3, Chugh R4, Diamond J1, Aljumaily R2, Stagg R5, Dupon

Add to Reading List

Source URL: publications.oncomed.com

Download Document from Source Website

File Size: 361,52 KB

Share Document on Facebook

Similar Documents